Given rises to six-month high as earnings beat estimates


Given rose to the highest level in six months after the Israeli maker of pill size cameras to diagnosis digestive tract ailments reported quarterly sales and profit that surpassed estimates. Sales rose to $48.5 million from $44.9 million a year earlier, and the company reported earnings of 25 cents per share, ahead of the 21 cents that analysts had forecast. “We recommend that investors buy shares of Given following last night’s strong results,’’ wrote Bryan Brokmeier, an analyst at Maxim Group in New York.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of